Sentences with phrase «manufacturers of these drugs»

Or might it be because the original manufacturer of the drug knew of the risks of uterine rupture?

According to reports, manufacturers of these drugs knew about the risks but failed to properly warn physicians and patients.

Lawsuits against manufacturers of the drug Invokana have been increasing rapidly as reports of serious injuries rise.

Many factors have been linked to these price increases, including shortages in the manufacturing supply chain (leading to reduced production) and a reduction in the number of manufacturers of a drug (resulting in insufficient competition).

Lawsuits against manufacturers of these drugs have picked up momentum in recent months due to an onslaught of serious health problems and adverse event reports.

«The manufacturer of a drug has no influence or control over the prices charged by a secondary wholesaler to a hospital or pharmacy,» reads part of a statement on the PhRMA web site, the industry's trade association group.

A 2002 study in the Journal of the American Medical Association (JAMA) found that 87 percent of guideline authors received industry funding and 59 percent were paid by the manufacturer of a drug affected by the guidelines they wrote.

The clinical trial was sponsored by Duchesnay Inc., the manufacturer of the drug.

Amgen, the manufacturer of the drug and the provider of the drugs used in the U-M study, is currently testing on osteoporosis patients.

According to Merck & Co., the manufacturer of the drug, Gardasil protects against HPV for five years.

All good questions and all without answers from the manufacturers of these drugs.

• What the experts say: Though the FDA did not conclude definitively that the events reported were induced by the drugs, the agency in June 2009 requested that the manufacturers of these drugs include a precaution about neuropsychiatric events in their prescribing information and labeling.

In their Lipitor diabetes lawsuits, the plaintiffs claims that the drug manufacturer was aware of these side effects but did not act to make sure that the public knew about them, too It wasn't until 2012 - six years after Lipitor entered the market - that the U.S. Food and Drug Administration demanded that manufacturers of drugs that lower cholesterol, also known as statins, modify their labeling to include some of the more dangerous risks involved, including memory loss and diabetes.

In July 2008 the FDA issued an alert notifying the manufacturers of these drugs that they would be required to develop a medication guide and add a «black box» warning to the prescribing information included with these bad drugs.

Quite a number of lawsuits have been filed against the manufacturers of these drugs due to their failure to warn users of the associated dangers.

Many of these lawsuits claim that the manufacturers of these drugs failed to warn patients and physicians of the increased risks of kidney failure, heart attacks, and ketoacidosis.